Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S McDonnell

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Gynecologic Oncology|November 12, 2021
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancerBeryl L Manning-Geist, Sushmita B Gordhandas, Dilip D Giri, et al.
Journal of Medical Genetics|March 16, 2007
Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational studyOliver W J Quarrell, Alan S Rigby, L Barron, et al.
Journal for Immunotherapy of Cancer|June 7, 2020
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trialDmitriy Zamarin, Sven Walderich, Aliya Holland, et al.
Nature Genetics|October 15, 1998
Evidence for a prostate cancer susceptibility locus on the X chromosomeJ Xu, D Meyers, D Freije, et al.
Investigative Ophthalmology & Visual Science|December 18, 2024
Consensus Recommendations for Studies of Outflow Facility and Intraocular Pressure Regulation Using Ex Vivo Perfusion ApproachesTed S Acott, Michael P Fautsch, Weiming Mao, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Gynecologic Oncology|November 12, 2021
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancerBeryl L Manning-Geist, Sushmita B Gordhandas, Dilip D Giri, et al.
Journal of Medical Genetics|March 16, 2007
Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational studyOliver W J Quarrell, Alan S Rigby, L Barron, et al.
Journal for Immunotherapy of Cancer|June 7, 2020
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trialDmitriy Zamarin, Sven Walderich, Aliya Holland, et al.
Nature Genetics|October 15, 1998
Evidence for a prostate cancer susceptibility locus on the X chromosomeJ Xu, D Meyers, D Freije, et al.
Investigative Ophthalmology & Visual Science|December 18, 2024
Consensus Recommendations for Studies of Outflow Facility and Intraocular Pressure Regulation Using Ex Vivo Perfusion ApproachesTed S Acott, Michael P Fautsch, Weiming Mao, et al.
Pageof 8